Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Critical Alert CommonPath Enterprise

K-Number: K193043 · 2020-05-11

Decision Date2020-05-11
Product CodeMSX
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Critical Alert CommonPath Enterprise is a medical device manufactured by Critical Alert. It received FDA 510(k) clearance on 2020-05-11 under approval number K193043. The device is classified under product code MSX. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Critical Alert CommonPath Enterprise?

Critical Alert CommonPath Enterprise is a medical device that received FDA 510(k) clearance on 2020-05-11. It is manufactured by Critical Alert. The 510(k) number is K193043.

When was Critical Alert CommonPath Enterprise approved by the FDA?

Critical Alert CommonPath Enterprise received FDA 510(k) clearance on 2020-05-11, under approval number K193043.

What company makes Critical Alert CommonPath Enterprise?

Critical Alert CommonPath Enterprise is manufactured by Critical Alert.

What is the FDA product code for Critical Alert CommonPath Enterprise?

The FDA product code for Critical Alert CommonPath Enterprise is MSX.

Related Clinical Trials

Related Devices (Code: MSX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.